16.45
Schlusskurs vom Vortag:
$16.50
Offen:
$16.43
24-Stunden-Volumen:
47,832
Relative Volume:
0.46
Marktkapitalisierung:
$372.50M
Einnahmen:
$148.58M
Nettoeinkommen (Verlust:
$30.97M
KGV:
13.16
EPS:
1.25
Netto-Cashflow:
$22.33M
1W Leistung:
+12.78%
1M Leistung:
+36.22%
6M Leistung:
+2.78%
1J Leistung:
+12.78%
National Research Corp Stock (NRC) Company Profile
Firmenname
National Research Corp
Sektor
Branche
Telefon
(402) 475-2525
Adresse
1245 Q STREET, LINCOLN
Compare NRC vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NRC
National Research Corp
|
16.45 | 373.51M | 148.58M | 30.97M | 22.33M | 1.25 |
|
VEEV
Veeva Systems Inc
|
179.38 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.70 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.25 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.92 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.12 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
National Research Corp Aktie (NRC) Neueste Nachrichten
What Makes National Research Corporation (NRC) a Good Investment Choice? - Insider Monkey
Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - Benzinga
National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving AverageTime to Sell? - MarketBeat
National Research Corporation (NRC) Announces $60 Million Stock Buyback - GuruFocus
National Research Corporation (NRC) Approves $60 Million Stock B - GuruFocus
NRC falls after announcing $60 million share repurchase program - MSN
Healthcare data firm NRC Health earmarks $60M to buy back stock - Stock Titan
Lam Research Corporation $LRCX Shares Sold by Swiss National Bank - MarketBeat
Aug Ideas: How correlated is National Research Corporation to the S P5002026 Earnings & Verified Chart Pattern Signals - baoquankhu1.vn
Whats the RSI of National Research Corporation stockJuly 2025 Fed Impact & Daily Price Action Insights - baoquankhu1.vn
Can National Research Corporation be recession proofTrade Risk Report & High Return Stock Watch Alerts - baoquankhu1.vn
National Research 2025 10-K: Revenue $137.4M, EPS $0.50 - TradingView
Busan Facilities Corp. Registers 11 Staff as National Researchers for AI R&D Push - en.sedaily.com
National Research Corporation (NRC) Hits Record High in Recurrin - GuruFocus
$152M in recurring healthcare contracts puts NRC Health at new high - Stock Titan
National Research Corporation (NASDAQ:NRC) Sees Significant Growth in Short Interest - MarketBeat
NRC Should I Buy - Intellectia AI
Info-Tech Research Group's AI-Powered HR Team Transformation Earns National Recognition From HRD Canada - Yahoo Finance
NRC PE Ratio & Valuation, Is NRC Overvalued - Intellectia AI
AI Stocks: Is Noble Corporation plc stock a hidden gemJuly 2025 Highlights & High Accuracy Buy Signal Tips - baoquankhu1.vn
NRC | National Research Corporation Common FinancialsIncome Statement - Quiver Quantitative
NRC (NRC) CFO Harrison purchases 8,000 shares in open-market trade - Stock Titan
Nvidia Expands India Partnerships Amid $1 Billion National AI Initiative Focused On Sovereign Models, Startup Funding And ResearchNVIDIA (NASDAQ:NVDA) - Benzinga
National Research Corp (NRC) director receives 8,819 stock options grant - Stock Titan
Wolbachia-Aedes Mosquito Suppression Strategy - The National Environment Agency
Institutional holders disclose 11.7% in National Research Corp (NRC) - Stock Titan
Selling holders offer 14.5M National Research (NASDAQ: NRC) shares - Stock Titan
NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27% - Yahoo Finance
New Voices in Sciences, Engineering, and Medicine - National Academies of Sciences, Engineering, and Medicine
Transcript: National Research Q4 2025 Earnings Conference Call - Benzinga
How NRC Health's patient experience tech rose to #1 in 2026 KLAS - Stock Titan
National Research Q4 Earnings Call Highlights - MarketBeat
National Research Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: NRC Health Q4 2025 revenue declines, stock drops - Investing.com India
NRC 2025 Earnings Report: $11.6M Annual Profit | Healthcare AdvisorNews and Statistics - IndexBox
National Research: Q4 Earnings SnapshotCentral - Central - News Channel Nebraska
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
National Research: Fourth Quarter Earnings Overview - Bitget
The Zacks Analyst Blog Highlights Meta Platforms, Palantir Technologies, Amphenol and National Research - Nasdaq
Top Research Reports for Meta, Palantir and Amphenol - TradingView
Top research reports for Meta, Palantir and Amphenol - MSN
National Research Says Pairing NPS With HCAHPS Can Boost Patient Experience—and Reimbursement - MarketBeat
The group led by Barbacid at CNIO completely eliminates pancreatic tumours in mice with no resistance developingCentro Nacional de Investigaciones Oncológicas - Centro Nacional de Investigaciones Oncológicas - CNIO
National Research (NASDAQ:NRC) Stock Price Passes Above 200-Day Moving AverageTime to Sell? - MarketBeat
2025 year in review: Quantum computing development accelerates - Constellation Research
Day Trade: Can National Research Corporation withstand a market correction2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
IQVIA Holdings Inc. $IQV Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund - Defense World
National Research (NASDAQ:NRC) Hits New 12-Month HighShould You Buy? - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $20.99 Million Holdings in Monster Beverage Corporation $MNST - Defense World
Treasury Yields: Is National Research Corporation stock technically oversoldWeekly Investment Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
With 51% ownership, National Research Corporation (NASDAQ:NRC) boasts of strong institutional backing - Yahoo Finance
Finanzdaten der National Research Corp-Aktie (NRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):